Gerard Hoehn

Gerard Hoehn serves as the Sr. Medical Director at Blueprint Medicines since August 2019, previously holding the position of Associate Director at Teva Oncology from April 2013 to September 2017. Gerard Hoehn obtained a Doctor of Philosophy (PhD) in Microbiology/Immunology from the University of Rochester School of Medicine between 1986 and 1991, and earlier earned a PhD in Biochemistry from Beloit College from 1982 to 1986.